The University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a comprehensive cancer center and autonomous university of the University of Texas System in Houston, Texas, located within the Texas Medical Center. It is the largest cancer center in the world and one of the original three NCI-designated comprehensive cancer centers in the United States. It is named after Monroe Dunaway Anderson, whose foundation helped fund the hospital after the Texas Legislature set aside $500,000 for a cancer hospital in 1941.

Nature Index (Springer Nature) puts MD Anderson at No. 10 worldwide in its 2026 Research Leaders table for healthcare institutions. Its 2025 Share there was 112.48, against 112.70 in 2024, a change of -0.2%, from a Count of 507.

As of 2023 MD Anderson hosted the highest number of cancer clinical trials in the world and had received more NCI-funded projects than any other U.S. institute; it invested $1.2 billion in research in fiscal 2023. U.S. News & World Report ranked it No. 1 in cancer care for 2024-2025, its tenth consecutive year at the top, and Newsweek placed it No. 1 in oncology among the World's Best Specialized Hospitals 2024. Besides patient care, it awards degrees from bachelor's to M.D./Ph.D. level, and in 1996 the Pan American Health Organization set up a collaborating center for supportive cancer care at its Pain Research Group.

Sources of this text: Wikipedia · Nature Index (Springer Nature)